J&J faulty hip implant patients may get ₹10 lakh extra compensation1 min read . Updated: 12 Feb 2019, 01:12 AM IST
- ₹10 lakh additional compensation has been recommended for those patients who have had two revision surgeries
- There is a rider, however: if such patients have already been reimbursed by the company, they will get ₹5 lakh
New Delhi: The government committee on the Johnson and Johnson (J&J) faulty hip implant case has recommended ₹10 lakh in additional compensation for those who have had two revision surgeries. There is a rider, however: if such patients have already been reimbursed by the company, they will get ₹5 lakh.
The expert committee, which met on 4 February, recommended the additional compensation without making any modifications in the formula that was approved in November for the quantum of compensation to be awarded to people fitted with the faulty implants.
“The patients’ concerns have been taken care of and hence it was decided to increase the compensation for those who have had two revision surgeries," said one of the persons mentioned above. The government started fresh discussions in January after J&J and a group of patients expressed concerns. Both the parties shared their views with the committee on 9 January. “The committee will now start reviewing the cases for compensation," the second person said.
The panel’s decision to leave the formula undisturbed was prompted by a Supreme Court verdict on 12 January accepting the compensation. A bench headed by Chief Justice of India Ranjan Gogoi also directed the Centre to widely publicise an 11 September notice asking affected people to approach the panel set up to look into the compensation issue.
“The Supreme Court expressed its satisfaction on the steps that were being taken by the central government. Its verdict sealed everything. Therefore, there is no point in modifying the formula," said the first person mentioned above.
The apex court had on 5 October sought the view of the expert committee on the implants and directed it to file its report within two months. This followed the filing of a public interest litigation by Arun Kumar Goenka, a businessman, who wanted protection of the fundamental rights of 14,525 people who had undergone the acetabular surface replacement hip implant surgeries since 2005.